Literature DB >> 4019782

Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

F Takahashi, K M Das.   

Abstract

Patients with idiopathic ulcerative colitis (UC) have a colonbound antibody (CCA-IgG) that reacts with colon tissue extracts. We have partially characterized a colonic protein that is specifically recognized by CCA-IgG. CCA-IgG was eluted from operative colon specimens from 10 patients with UC. A colon tissue-bound IgG was similarly eluted from six patients with Crohn's colitis, two with ischemic colitis, and one with diverticulitis. Purified serum IgG from patients with Crohn's disease, from normal subjects and a patient with myeloma were also used as additional controls. For detection of antigen(s), tissue extracts were prepared from 26 specimens of colon (UC, 12; Crohn's disease, 6; normal, 4; other controls, 4), 8 specimens of human normal stomach, duodenum, ileum, and liver (2 each). Tissue extracts were also prepared from rats and mice, including germ-free rat colons and rat's fetal colons. Immunorecognition of CCA-IgG to the tissue extracts was examined by affinity-column chromatography and by transblot analysis. Tissue-extracted proteins were electrophoresed in SDS-polyacrylamide gel, transferred to nitrocellulose sheet, and probed with iodinated CCA-IgG, colonic IgG from other inflammatory bowel disease patients, UC serum IgG, and control serum IgG. Although many proteins were present in colon tissue extracts, 9 of 10 CCA-IgG consistently recognized a protein of 40 kD. None of the nine IgG preparations from colon specimens of patients with Crohn's colitis and other colonic inflammatory diseases reacted with the 40-kD protein. Five of six symptomatic UC serum IgG and none of eight control serum IgG reacted with the 40-kD protein. The 40-kD protein was present in all colon specimens and it appeared to be organ specific. It was absent in mouse and rat tissues, including colon. The 40-kD protein is not actin and nor a part of the Ig molecule. These results suggest that the 40-kD protein is a colonic "autoantigen" that may initiate a specific IgG antibody response in UC.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4019782      PMCID: PMC423773          DOI: 10.1172/JCI111963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen.

Authors:  P Perlmann; S Hammarström; R Lagercrantz; D Campbell
Journal:  Proc Soc Exp Biol Med       Date:  1967-07

2.  Escherichia Coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease.

Authors:  W R Thayer; M Brown; M H Sangree; J Katz; T Hersh
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

3.  Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases.

Authors:  R Lagercrantz; S Hammarström; P Perlmann; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

4.  Antigen from colon of germfree rats and antibodies in human ulcerative colitis.

Authors:  P Perlmann; S Hammarström; R Lagercrantz; B E Gustafsson
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

5.  Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis.

Authors:  T Hibi; S Aiso; M Ishikawa; M Watanabe; T Yoshida; K Kobayashi; H Asakura; S Tsuru; M Tsuchiya
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

6.  Detection and partial characterization of Crohn's disease tissue specific proteins recognized by Crohn's disease sera.

Authors:  S Bagchi; K M Das
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

7.  Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism.

Authors:  W L Cleveland; N H Wassermann; R Sarangarajan; A S Penn; B F Erlanger
Journal:  Nature       Date:  1983 Sep 1-7       Impact factor: 49.962

8.  Antibody-dependent cell-mediated cytotoxicity in serum samples from patients with ulcerative colitis. Relationship to disease activity and response to total colectomy.

Authors:  K M Das; Y Kadono; G M Fleischner
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

9.  Autoantibodies in human ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

10.  In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells.

Authors:  P PERLMANN; O BROBERGER
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

View more
  53 in total

1.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease.

Authors:  L Helgeland; C Tysk; G Järnerot; K Kett; E Lindberg; D Danielsson; S N Andersen; P Brandtzaeg
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

Review 3.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 4.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

6.  Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.

Authors:  F Shanahan; B Leman; R Deem; A Niederlehner; M Brogan; S Targan
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

Review 7.  Inflammatory bowel disease: Moving toward a stem cell-based therapy.

Authors:  Giacomo Lanzoni; Giulia Roda; Andrea Belluzzi; Enrico Roda; Gian Paolo Bagnara
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

8.  Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins.

Authors:  C C Fox; L M Lichtenstein; J K Roche
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

9.  Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis.

Authors:  Hideji Nakamura; Kenya Yoshida; Kazuhiro Ikegame; Yoshihiko Kishima; Hirokazu Uyama; Hirayuki Enomoto
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

10.  Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?

Authors:  P R Gibson; E van de Pol; P J Barratt; W F Doe
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.